logo

Last Update

This profile was last updated on 6/12/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Sandra Milligan?

Sandra A. Milligan

Senior Vice President, Global Regulatory Affairs and Clinical Safety

Merck & Co. , Inc.

HQ Phone:  (908) 740-4000

Direct Phone: (650) ***-****direct phone

Email: s***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Merck & Co. , Inc.

2000 Galloping Hill Road

Kenilworth, New Jersey,07033

United States

Company Description

For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work ...more

Background Information

Employment History

Vice President, Global Head of Inflammation, Virology and Ophthalmology

Genentech , Inc.


Global Regulatory Therapeutic Area Head

Amgen Inc.


Affiliations

Drug Information Association

Board Member


Roche Group

Member


DIA

Board Member


Food and Drug Administration

Biologics Industry Representative of the Risk Communication Advisory Committee


The Food and Drug Law Institute

Member of the Strategic Planning Committee and the FDLI Drugs and Biologic Committee


Pharma IQ

Board Member


National Committee for Clinical Laboratory Standards

Board Member


Education

The George Washington University School of Medicine


UC Irvine


JD


Web References(35 Total References)


DIA - DIA Names Four New Fellows at 2017 Global Annual Meeting

www.diaglobal.org [cached]

Sandra A. Milligan, MD, JD (Chair, Fellows of DIA) - immediate past president of DIA; Senior Vice President and Head of Regulatory Affairs and Clinical Safety, Merck Research Laboratories


DIA - Sandra A. Milligan, MD, JD

www.diaglobal.org [cached]

Sandra A. Milligan,
Dr. Milligan currently serves as Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety at Merck, consisting of the global Regulatory, Safety, and Chemistry, Manufacturing and Control functions of Merck Research Laboratories. Previously serving as Vice President, Global Regulatory, Immunology, Respiratory, Infectious Diseases and Ophthalmology for Genentech/Roche, she developed and directed global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. Previous to Genentech/Roche, Dr. Milligan served at Amgen for almost ten years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise; Head of Regulatory Communications Strategy & Operations; and as Senior Counsel for the Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory, and safety groups. In addition to serving on the DIA Board of Directors and as the Immediate Past President, Dr. Milligan served as the DIA Board of Directors President from July 2015 - June 2016, as Program Chair for the 2013 DIA Annual Meeting in Boston, as well as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. Dr. Milligan is a graduate of The George Washington University School of Medicine and the Georgetown University Law Center. Sandra A. Milligan, Sandra A. Milligan, Sandra A. Milligan,


www.diaglobal.org

Sandra A. Milligan, JD, MD
DIA | Biography Sandra A. Milligan, JD, MD Sandra A. Milligan, MD, JD, currently serves as Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety of Merck, consisting of the global Regulatory, Safety and CMC functions of Merck Research Laboratories. She previously served as Vice President, Global Regulatory, Immunology, Respiratory, Infectious Diseases and Ophthalmology for Genentech/Roche where she developed and directed global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. Previous to Genentech/Roche she served at Amgen for almost 10 years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise, as Head of Regulatory Communications Strategy & Operations, and as Senior Counsel for the Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory and safety groups. In addition to serving on the DIA Board of Directors and current President-Elect, Sandra has served as the Program Chair for the DIA 2013 Annual Meeting in Boston, as well as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. Sandra is a graduate of The George Washington University School of Medicine and the Georgetown University Law Center and attended UC Irvine for undergraduate studies.


DIA - Sandra A. Milligan, MD, JD

www.diaglobal.org [cached]

Sandra A. Milligan,
Dr. Milligan currently serves as Senior Vice President and Head of Global Regulatory Affairs and Clinical Safety at Merck, consisting of the global Regulatory, Safety, and Chemistry, Manufacturing and Control functions of Merck Research Laboratories. Previously serving as Vice President, Global Regulatory, Immunology, Respiratory, Infectious Diseases and Ophthalmology for Genentech/Roche, she developed and directed global strategic regulatory plans to facilitate and optimize product development, regulatory approval, and commercialization. Previous to Genentech/Roche, Dr. Milligan served at Amgen for almost ten years in various roles, including Global Regulatory Therapeutic Area Head for the Bone franchise; Head of Regulatory Communications Strategy & Operations; and as Senior Counsel for the Development, Regulatory & Compliance Law Group, where she provided strategy for development, regulatory, and safety groups. In addition to serving on the DIA Board of Directors and as the Immediate Past President, Dr. Milligan served as the DIA Board of Directors President from July 2015 - June 2016, as Program Chair for the 2013 DIA Annual Meeting in Boston, as well as co-chair of the Public Policy/Health Care Compliance/Regulatory Law Annual Meeting track. Dr. Milligan is a graduate of The George Washington University School of Medicine and the Georgetown University Law Center. Fellows of DIA Fellows of DIA MD, JD" width="108" height="108"> Sandra A. Milligan,


DIA 2017 - Disclosures

www.diaglobal.org [cached]

Sandra Milligan, OTHER SUPPORT-Employee of Merck & Co., Inc, STOCK SHAREHOLDER-Amgen, Merck & Co., Inc.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory